Richard A. Paulson - Net Worth and Insider Trading
Richard A. Paulson Net Worth
The estimated net worth of Richard A. Paulson is at least $1 Million dollars as of 2024-06-02. Richard A. Paulson is the President and CEO of Karyopharm Therapeutics Inc and owns about 1,153,697 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $1 Million. Details can be seen in Richard A. Paulson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard A. Paulson has not made any transactions after 2024-05-06 and currently still holds the listed stock(s).
Transaction Summary of Richard A. Paulson
Richard A. Paulson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard A. Paulson owns 2 companies in total, including Karyopharm Therapeutics Inc (KPTI) , and bluebird bio Inc (BLUE) .
Click here to see the complete history of Richard A. Paulson’s form 4 insider trades.
Insider Ownership Summary of Richard A. Paulson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-05-06 | director & President and CEO |
| BLUE | bluebird bio Inc | 2023-04-03 | director |
Richard A. Paulson Latest Holdings Summary
Richard A. Paulson currently owns a total of 1 stock. Richard A. Paulson owns 1,153,697 shares of Karyopharm Therapeutics Inc (KPTI) as of May 6, 2024, with a value of $1 Million.
Latest Holdings of Richard A. Paulson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-05-06 | 1,153,697 | 0.96 | 1,106,742 |
Holding Weightings of Richard A. Paulson
Richard A. Paulson Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard A. Paulson has made a total of 26 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 3,576 shares on May 6, 2024, which brought Richard A. Paulson around $4,041.
Insider Trading History of Richard A. Paulson
- 1
Richard A. Paulson Trading Performance
Richard A. Paulson Ownership Network
Richard A. Paulson Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Richard A. Paulson is the director & President and CEO of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & Chief Medical Officer Reshma Rangwala , EVP & CFO & Treasurer Michael Mason , and EVP & Chief Development Officer Stuart Poulton .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Richard A. Paulson made 20 insider transaction in Karyopharm Therapeutics Inc (KPTI) with a net sale of 199,120. Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 66,291 shares made by Michael Mason , a net sale of 47,442 shares made by Sohanya Roshan Cheng , and a net sale of 38,193 shares made by Michael Mano .
In summary, during the past 3 months, insiders sold 17,501 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 17,501 shares. During the past 18 months, 423,756 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,616 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Richard A. Paulson Mailing Address
Above is the net worth, insider trading, and ownership report for Richard A. Paulson. You might contact Richard A. Paulson via mailing address: 85 Wells Avenue, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
